Nurşah Eker, Burcu Tufan Taş, Ömer Doğru, Emel Şenay, Ayşe Gülnur Tokuç, & Ahmet Koç. (2022). Successful Treatment of Refractory Graft-Versus-Host Disease with Ruxolitinib in a Child after Autologous Stem Cell Transplantation. Galenos Yayinevi.
Čikaški stil citiranja (17. izdanje)Nurşah Eker, Burcu Tufan Taş, Ömer Doğru, Emel Şenay, Ayşe Gülnur Tokuç, i Ahmet Koç. Successful Treatment of Refractory Graft-Versus-Host Disease with Ruxolitinib in a Child After Autologous Stem Cell Transplantation. Galenos Yayinevi, 2022.
MLA način citiranja (9. izdanje)Nurşah Eker, et al. Successful Treatment of Refractory Graft-Versus-Host Disease with Ruxolitinib in a Child After Autologous Stem Cell Transplantation. Galenos Yayinevi, 2022.
Upozorenje: Ovi citati možda nisu uvijek 100% točni.